AZN vs EXPD · P/E 28, $288.38B cap vs P/E 26, rev $6.29B
AstraZeneca PLC (AZN) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported EXPD revenue for 2026-06-30 was $6.29B. Net income was $495.8M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the AZN and EXPD stock pages for the full models.
Not investment advice.